IMCL-9815: Cetuximab plus radiotherapy superior to radiation alone in SCCHN

Barbara Burtness, MD, highlights data from the phase 3 IMCL-9815 trial, which demonstrated that patients with locally advanced squamous cell carcinoma of the head and neck benefitted more from treatment with cetuximab plus radiation therapy than radiation alone, regardless of HPV-p16 status.